<b>Background/Objectives:</b> There is limited data regarding the association of anti-drug antibody (ADA) levels with the efficacy of anti-tumor necrosis factor (anti-TNF) therapy in patients with inflammatory bowel disease (IBD). This evidence concerns the gene ADA and inflammatory bowel disease.